Skip to main content

Table 2 Variables related to mechanical ventilation in all patients, and comparison between survivors and non-survivors.

From: Lung Function and Organ Dysfunctions in 178 Patients Requiring Mechanical Ventilation During The 2009 Influenza A (H1N1) Pandemic

 

Day 0

Day 3

Day 7

Day 10

 

All

S

NonS

P

All

S

NonS

P

All

S

NonS

P

All

S

NonS

P

N

178

93

85

 

152

89

63

 

129

80

42

 

73

38

35

 

Tidal volume (ml/kg of IBW)

7.8 ± 2

8.0 ± 2

7.7 ± 2

.35

7.9 ± 2

8.0 ± 2

7.8 ± 2

.46

7.9 ± 2

8.2 ± 2

7.5 ± 1

.02

8.1 ± 2

8.3 ± 2

7.9 ± 2

.35

Plateau pressure (cmH2O)

26 ± 7

25 ± 6

27 ± 8

.09

24 ± 7

24 ± 6

26 ± 8

.10

24 ± 7

23 ± 6

27 ± 8

.01

25 ± 8

24 ± 7

26 ± 8

.16

PEEP. (cm H2O)

10 (7 to 14)

10 (7 to 14)

10 (8 to 14)

.34

10 (7 to 14)

10 (7 to 12)

12 (7 to 14)

.05

10 (6 to 14)

8 a (5 to 12)

12 (8 to 15)

.003

10 (6 to 14)

8 b (6 to 12)

12 (8 to 15)

.008

Driving Pressure (cm H2O)

16 ± 6

15 ± 5

17 ± 6

..05

15 ± 6

14 ± 5

16 ± 6

.16

15 ± 6

14 ± 5

16 ± 7

.26

15 ± 7

14 ± 5

16 ± 8

.21

Respiratory rate (cycles/min)

21 ± 5

21 ± 5

21 ± 4

.66

21 ± 5

20 ± 4

22 ± 5

.22

21 ± 5

20 ± 4

22 ± 5

.15

20 ± 6

20 ± 5

23 ± 6

.03

PaO2/FIO2

136 (85 to 204)

146 (110 to 215)

125 (71 to 197)

.02

178 a (125 to 251)

220 a (156 to 287)

134 (84 to 185)

< 0.001

195 a (142 to 260)

230 a (172 to 292)

144 (88 to 190)

< 0.001

172 a (109 to 235)

212 a (164 to 270)

123 (80 to 160)

< 0.001

FIO2 (%)

80 (25 to 100)

70 (50 to 100)

100 (70 to 100)

< 0.001

60 a (40 to 70)

50 a (40 to 60)

65 a (50 to 100)

< 0.001

50 a (40 to 65)

50 a (40 to 55)

60a (45 to 85)

< 0.001

50 a (41 to 70)

47 a (40 to 50)

80 a (50 to 100)

< 0.001

  1. Data are presented as means ± standard deviations, and medians and (IQR)
  2. Vt, Tidal volume. IBW, predicted body weight. S, Survivors. NonS, Non-survivors. P, Intergroup comparisons (between survivors vs. non-survivors) at each day are shown.
  3. For intragroup comparisons over time: Days 3, 7 and 10 are compared to Day 0 values, in all patients, in survivors and in non-survivors.
  4. a P <.001; b P <.01